Zhitong Finance App News, Xiaofang Pharmaceutical (603207.SH) issued a stock price change announcement stating that the company's operating fundamentals have not changed. Its main business is the production, development and sale of topical drugs. The products currently on sale are mainly household topical medicines, and do not involve innovative drugs. The company is concerned about recent media reports about the company's drug “compound cypress tincture” to treat hair loss. The drug is currently in the pre-clinical research stage and still needs to be submitted to the State Drug Administration for clinical trials, and there is uncertainty about subsequent research and development.

Zhitong Finance App News, Xiaofang Pharmaceutical (603207.SH) issued a stock price change announcement stating that the company's operating fundamentals have not changed. Its main business is the production, development and sale of topical drugs. The products currently on sale are mainly household topical medicines, and do not involve innovative drugs. The company is concerned about recent media reports about the company's drug “compound cypress tincture” to treat hair loss. The drug is currently in the pre-clinical research stage and still needs to be submitted to the State Drug Administration for clinical trials, and there is uncertainty about subsequent research and development.